(NASDAQ: QDEL) Quidelortho's forecast annual revenue growth rate of 4.11% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 11.39%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 61.07%.
Quidelortho's revenue in 2026 is $2,714,400,000.On average, 10 Wall Street analysts forecast QDEL's revenue for 2026 to be $191,838,668,960, with the lowest QDEL revenue forecast at $183,347,226,460, and the highest QDEL revenue forecast at $198,428,028,340. On average, 9 Wall Street analysts forecast QDEL's revenue for 2027 to be $199,854,590,680, with the lowest QDEL revenue forecast at $189,596,928,140, and the highest QDEL revenue forecast at $207,055,333,920.
In 2028, QDEL is forecast to generate $207,938,443,940 in revenue, with the lowest revenue forecast at $199,786,659,140 and the highest revenue forecast at $214,052,282,540.